报告题目： Development of prohibitin ligands to treat cancers, cardiac and inflammatory disorders
报 告 人：Laurent Désaubry Professor
CNRS-Strasbourg University, France & Tianjin University of Science and Technology, China
时 间： 2019 年 3 月 14 日（星期四） 中午12：00-1：00
地 点： 生理楼三层中厅
主 持 人： 孔炜 教授
Dr Laurent Désaubry is a CNRS research director in the Laboratory of Cardio-Oncology at the University of Strasbourg in France (website: http://desaubry.u-strasbg.fr/) and adjunct professor at Tianjin University of Science and Technology (TUST) in China. In 1992, he received a Ph.D. degree in medicinal chemistry from Strasbourg University. Next, he worked as a postdoctoral fellow at SUNY at Stony Brook, USA. He made another post-doctoral internship in Prof. Pierre Chambon’s laboratory in France before to get a CNRS senior scientist position at the University of Strasbourg-CNRS. He was promoted CNRS research director (corresponds to full professor) in 2014, and became also adjunct professor at TUST in 2015.